Literature DB >> 15627976

High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins.

Wanli Liu1, Ying-Hua Chen.   

Abstract

Although early studies have shown a close correlation between epitope density and epitope-specific humoral immune responses, few attempts have been made to quantitatively compare the antigenic and immunogenic differences between protein molecules bearing low or high degrees of epitope density, nor have studies quantitatively investigated the mechanism of B cell discrimination of monomeric antigens. In this study, we prepared glutathione S-transferase (GST) fusion proteins bearing various copies of the M2e epitope from the influenza virus M2 protein [GST-(M2e)8, GST-(M2e)4 and GST-(M2e)1], which were used to detect and compare the real-time kinetic binding with M2e-specific mAb by surface plasma resonance. Our data show clearly that fusion proteins bearing higher M2e epitope density resulted in higher average avidity for M2e-specific mAb. Furthermore, it was observed that fusion proteins bearing high M2e epitope density could induce polyclonal antibodies (pAb) with enhanced an average affinity constant (KA) for M2e epitope peptide compared to fusion proteins bearing low epitope density. The average KA of pAb induced by GST-(M2e)8 (3.08 x 10(8) M(-1) or 9.96 x 10(8) M(-1)) was up to two orders of magnitude greater than the average KA of pAb induced by GST-(M2e)1 (2.00 x 10(6) M(-1) or 3.43 x 10(6) M(-1)). Thus, the data presented here demonstrate that high epitope density in a single protein molecule significantly enhances antigenicity and immunogenicity. These findings enrich our knowledge of how epitope density might relate to the recognition, activation and antibody production processes of epitope-specific immature B cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15627976     DOI: 10.1002/eji.200425749

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  42 in total

1.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

Authors:  James J Moon; Heikyung Suh; Adrienne V Li; Christian F Ockenhouse; Anjali Yadava; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-12       Impact factor: 11.205

2.  Reorienting our view of particle-based adjuvants for subunit vaccines.

Authors:  Steven R Little
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Sang-Moo Kang; Li Wang; Ying-Chun Wang; Elena V Vassilieva; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

4.  Utilization of a photoactivatable antigen system to examine B-cell probing termination and the B-cell receptor sorting mechanisms during B-cell activation.

Authors:  Jing Wang; Shan Tang; Zhengpeng Wan; Yiren Gao; Yiyun Cao; Junyang Yi; Yanyan Si; Haowen Zhang; Lei Liu; Wanli Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-13       Impact factor: 11.205

5.  Optimization of a multivalent peptide vaccine for nicotine addiction.

Authors:  David F Zeigler; Richard Roque; Christopher H Clegg
Journal:  Vaccine       Date:  2019-02-13       Impact factor: 3.641

Review 6.  Conjugate Vaccine Immunotherapy for Substance Use Disorder.

Authors:  Paul T Bremer; Kim D Janda
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

7.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

8.  DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses.

Authors:  Huiling Wei; Stephen D Lenz; David H Thompson; Roman M Pogranichniy
Journal:  Viral Immunol       Date:  2012-07-20       Impact factor: 2.257

9.  DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1.

Authors:  Huiling Wei; Stephen D Lenz; David H Thompson; Roman M Pogranichniy
Journal:  Viral Immunol       Date:  2014-01-09       Impact factor: 2.257

10.  Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen.

Authors:  Rohan S Ingrole; Wenqian Tao; Jatindra N Tripathy; Harvinder S Gill
Journal:  Nano Life       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.